Ten leading SNPs were selected for stage 2a genotyping follow-up (Supplementary Table 2). Thirty leading SNPs were selected for stage 2b in silico exchange, according to P value (under the threshold of 5 × 10−5), N effective (≥70% of the total sample size) and evidence from supporting SNPs (Supplementary Table 3).
